Re: Combination therapy for Toxic Epidermal Necrolysis: It is time for anti-TNFa biologics comparison

Burns. 2020 Feb;46(1):245-246. doi: 10.1016/j.burns.2019.11.011. Epub 2019 Dec 18.

Authors

Christopher H Pham¹, T Justin Gillenwater¹, Warren L Garner²

Affiliations

¹ Division of Plastic and Reconstructive Surgery, Department of Surgery, LAC+USC Medical Center, Keck School of Medicine of the University of Southern California, United States.
² Division of Plastic and Reconstructive Surgery, Department of Surgery, LAC+USC Medical Center, Keck School of Medicine of the University of Southern California, United States. Electronic address: [email protected].

PMID: 31862281
DOI: 10.1016/j.burns.2019.11.011

No abstract available

Publication types

Letter
Comment

MeSH terms

Biological Products*
Burns*
Etanercept
Humans
Immunoglobulins, Intravenous
Stevens-Johnson Syndrome*

Substances

Biological Products
Immunoglobulins, Intravenous
Etanercept